
Provectus Therapeutics is building an ultra-precision predictive therapeutic platform to shape a new cancer care ecosystem with patient-centered solutions. Their cutting-edge AI-aided drug testing platform utilizes a single clinical sample to explore over 100 drug responses, predicting patients' response rates and drug resistance. This enables doctors and patients to receive a report on the tumor drug resistance profile after just 24 hours, facilitating personalized treatment plans.

Provectus Therapeutics is building an ultra-precision predictive therapeutic platform to shape a new cancer care ecosystem with patient-centered solutions. Their cutting-edge AI-aided drug testing platform utilizes a single clinical sample to explore over 100 drug responses, predicting patients' response rates and drug resistance. This enables doctors and patients to receive a report on the tumor drug resistance profile after just 24 hours, facilitating personalized treatment plans.